B cell depletion with ublituximab reshapes the T cell profile in multiple sclerosis patients-Reference-Cited by-同舟云学术

B cell depletion with ublituximab reshapes the T cell profile in multiple sclerosis patients

Published:2019-07 Issue: Volume:332 Page:187-197
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Lovett-Racke Amy E.,Gormley Matthew,Liu Yue,Yang Yuhong,Graham Calsey,Wray Sibyl,Racke Michael K.,Shubin Richard,Twyman Cary,Alvarez Enrique,Bass Ann,Eubanks James L.,Fox Edward

Funder

TG Therapeutics

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,Immunology,Immunology and Allergy

Reference48 articles.

1. T cell responsive to myelin basic protein in patients with multiple sclerosis;Allegretta;Science,1990

2. Phenotype and function of human T lymphocyte subsets: concensus and issues;Appay;Cytometry,2008

3. Multiple sclerosis: mechanisms and immunotherapy;Baecher-Allan;Neuron,2018

4. Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial;Bar-Or;Ann. Neurol.,2008

5. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?;Bar-Or;Ann. Neurol.,2010

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Knowledge about CD3+CD20+ T Cells in Patients with Multiple Sclerosis;International Journal of Molecular Sciences;2024-08-18

2. Evaluating the Therapeutic Potential of Ublituximab in the Treatment of MS: Design, Development and Place in Therapy;Drug Design, Development and Therapy;2024-07

3. Human regulatory memory B cells defined by expression of TIM-1 and TIGIT are dysfunctional in multiple sclerosis;Frontiers in Immunology;2024-04-30

4. Role of B Cells in Relapsing-Remitting and Progressive Multiple Sclerosis and Long-Term Effects of B Cell Depletion;Neurologic Clinics;2024-02

5. B cell depletion attenuates CD27 signaling of T helper cells in multiple sclerosis;Cell Reports Medicine;2024-01